Home Featured Page 89

Featured

Latest

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission

Vital 2024: Informational Session and Q&A

reMind Psychedelics Business Forum

Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to...

atai Life Sciences to Participate in Upcoming September Investor Conferences

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to...

PT439 – Introducing Hyphae Leaks: Not Your Average Psychedelic Podcast

Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD...

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine)...

COMPASS Pathways announces publication of first study evaluating potential of AI...

Perfect Your Craft and Deliver Your Best Results with Homecoming

EDITOR PICKS

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission

Vital 2024: Informational Session and Q&A

reMind Psychedelics Business Forum

Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to...

atai Life Sciences to Participate in Upcoming September Investor Conferences

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to...

PT439 – Introducing Hyphae Leaks: Not Your Average Psychedelic Podcast

Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD...

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine)...

COMPASS Pathways announces publication of first study evaluating potential of AI...

Perfect Your Craft and Deliver Your Best Results with Homecoming

EDITOR PICKS

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY